Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown Primary
OP-CUP
1 other identifier
interventional
30
1 country
2
Brief Summary
Adult patients suspected of Squamous Cell Carcinoma of Unknown Primary (SCCUP) will be prospectively enrolled at a tertiary head \& neck cancer center at Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. All patients will undergo Magnetic Resonance Imaging (MRI) and Positron Emission Tomography-Computerized Tomography (PET-CT) prior to examination in general anesthesia. During general anesthesia, Intraoperative Transoral Ultrasound (ITUS) will be performed prior to panendoscopy. Detected tumors will be registered with specified oropharyngeal sub-locations. Blinded to ITUS, a consultant head \& neck surgeon will perform panendoscopy. After examination, the surgeon is unblinded to ultrasound results. Final histopathology results from location-specified biopsies performed will be used as reference standard. The overall detection rate will be compared between ITUS, panendoscopy, PET-CT and MRI with sensitivity and specificity analysis. Oropharynx sub-location specific detection rate of ITUS vs. panendoscopy will be compared with logistic regression analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2023
CompletedStudy Start
First participant enrolled
February 21, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedMay 7, 2024
May 1, 2024
11 months
February 16, 2023
May 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Increased detection rate by adding ITUS to panendoscopy
The difference in proportion of patients with SCCUP where a primary tumor location is correctly detected by ITUS but not detected with panendoscopy alone.
Within 2-4 weeks after panendoscopy.
Secondary Outcomes (2)
Ultrasonographic features of primary tonsil and tongue base tumors
1 year
Comparison of detection rate of ITUS, panendoscopy, combined ITUS+panendoscopy, MRI and PET-CT for locating the primary tumor.
1 year
Other Outcomes (1)
Average time in minutes used to perform transoral ultrasound
1 year
Study Arms (1)
Intraoperative Transoral Ultrasound
EXPERIMENTALTransoral ultrasound of the tonsils and tongue base under general anesthesia.
Interventions
The tonsils and tongue base will be scanned transorally using high-frequency intraoperative ultrasound transducers. Direct contact with the tonsils through the mouth is achieved during general anesthesia.
Eligibility Criteria
You may qualify if:
- Cytology-verified cervical lymph node metastasis from squamous cell carcinoma in neck levels I-IV with HPV+ cytology.
- Booked for panendoscopic examination under general anesthesia.
- Pre-operative MRI and PET-CT available.
You may not qualify if:
- Unable to provide written informed consent.
- Unable to complete full surgical work-up including palatine- and lingual tonsillectomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rigshospitalet, Denmarklead
- The Novo Nordic Foundationcollaborator
Study Sites (2)
Århus University Hospital, Department of Otorhinolaryngology, Head & Neck Surgery
Aarhus, 8200, Denmark
Rigshospitalet, Department of Otorhinolaryngology, Head & Neck Surgery & Audiology
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tobias Todsen, MD, PhD
Rigshospitalet, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 16, 2023
First Posted
May 3, 2023
Study Start
February 21, 2023
Primary Completion
January 29, 2024
Study Completion
March 1, 2024
Last Updated
May 7, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share